Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

CPTA Welcomes Triplet Therapeutics Chief Medical Officer as Industry Co-Director

C-Path’s Critical Path to Therapeutics for the Ataxias Consortium is pleased to announce the appointment of Irina Antonijevi

New patient-level data will facilitate more efficient clinical trial design TUCSON, Ariz., April 12, 2021 — The Critical Path In

C-Path’s Critical Path to Sickle Cell Disease Consortium (CP-SCD) is pleased to announce Dr. David Readett of Pfizer as its firs

May 7, 2021

COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop Friday May 7, 2021 12:00 – 1:30 pm Ea

April 7, 2021

D. Kush, D. Warzel, M.A. Kush, A. Sherman, E.A. Navarro, R. Fitzmartin, F. Pétavy, J. Galvez, L.B. Becnel, F.L. Zhou, N. Harmon..

April 7, 2021

Interest in drug development for rare diseases has expanded dramatically since the Orphan Drug Act was passed in 1983,

April 7, 2021

April 7, 2021

April 7, 2021

April 7, 2021